National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 51890 [2024-13465]
Download as PDF
<![CDATA[
51890
Federal Register / Vol. 89, No. 119 / Thursday, June 20, 2024 / Notices
Respondents: Regional Partnership
Grants recipients. There are currently
two active cohorts (Round 6 and Round
7) of RPG recipients. There are 8 grant
recipients in Round 6 and 18 grant
recipients in Round 7. Regional
Partnership Grants recipients, include
state agencies, a judicial court state
agency, and community-based
organizations (mental health and
healthcare community service
providers).
Total Burden Estimates
The Round 6 cohort will complete
projects by September 2024, with a
Final Report due in fiscal year (FY)25.
The Round 7 cohort will continue work
through September 2027, with a Final
Report due in FY28. There are 8 grant
Regional partnership grants final report outline ......................
Estimated total burden for both cohorts (FY25–FY28) ....
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: Title IV, part B, subpart 2—
Promoting Safe and Stable Families,
Section 437(f) of the Social Security Act
(42 U.S.C. 629g(f)).
Mary C. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2024–13479 Filed 6–18–24; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
17:08 Jun 18, 2024
Jkt 262001
Total number
of responses
per
respondent
Total
number of
respondents
Instrument
VerDate Sep<11>2014
recipients in Round 6 and 18 grant
recipients in Round 7. This request
includes burden estimates for both
cohorts. If needed, ACF will request an
extension to allow for FY28 reporting in
2027. Estimated burden for Round 6
grant recipients is 480 hours in FY 2025.
Estimated burden for Round 7 grant
recipients is 1080 hours in FY 2028.
RPG Round 6 (FY25 Reporting).
RPG Round 7 (FY28 Reporting).
................................................
60
480
1
60
1080
........................
........................
1,560
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Development of Medical
Countermeasures for Biodefense and
Emerging Infectious Diseases, Research Area
002—Therapeutic Candidates (N01).
Date: July 31–August 2, 2024.
Time: 10:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G13B,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Yong Gao, Ph.D., Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, National
Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers
Lane, Room 3G13B, Rockville, MD 20892–
7616, (240) 669–5048, gaoL2@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
[FR Doc. 2024–13465 Filed 6–18–24; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
Total burden
hours
1
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: June 14, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
Average
burden hours
per response
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health Center for
Scientific Review; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR Panel;
Maximizing Investigators Research Award
(MIRA).
Date: July 16–17, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Heidi B Friedman, Ph.D.,
Senior Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 907–H,
Bethesda, MD 20892, (301) 379–5632,
hfriedman@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Infectious Disease and
Immunology A.
Date: July 16–17, 2024.
Time: 9:00 a.m. to 8:00 p.m.
E:\FR\FM\20JNN1.SGM
20JNN1
]]>Agencies
[Federal Register Volume 89, Number 119 (Thursday, June 20, 2024)]
[Notices]
[Page 51890]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13465]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Development of Medical
Countermeasures for Biodefense and Emerging Infectious Diseases,
Research Area 002--Therapeutic Candidates (N01).
Date: July 31-August 2, 2024.
Time: 10:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G13B,
Rockville, MD 20892 (Video Assisted Meeting).
Contact Person: Yong Gao, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3G13B, Rockville, MD
20892-7616, (240) 669-5048, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: June 14, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-13465 Filed 6-18-24; 8:45 am]
BILLING CODE 4140-01-P
